Teva announces US launch of Vigabatrin

Drug Discovery |  News | 0 Comment | 08 Feb, 2019

Teva Pharmaceutical Industries has announced the launch of a generic version of Sabril®1 (vigabatrin) tablets, 500 mg in the US, the first generic version of Sabril® (viga...Read more

Perrigo to launch its AB rated generic Zovirax cream

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Zovirax® Cream,...Read more

BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

BioLineRx Ltd., an Israeli clinical-stage biopharmaceutical company focused on oncology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to it...Read more

Reaction Biology Corporation buys ProQinase GmbH

Drug Discovery |  News | 1 Comment | 05 Feb, 2019

Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange transaction through which RBC has acquired all the shares of ProQinase G...Read more

I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study

Drug Discovery |  News | 0 Comment | 04 Feb, 2019

I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune disease...Read more

FDA expands Lilly's ALIMTA Label

Drug Discovery |  News | 0 Comment | 01 Feb, 2019

Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed for injection) in combination with KEYTRUDA® (pembrolizumab...Read more

Neurocrine Biosciences collaborates with Voyager Therapeutics

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy pro...Read more

Pfizer and Lilly announce top-line results of Tanezumab

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis (OA) pain. As per ...Read more

J&J announces USFDA approval of IMBRUVICA

Drug Discovery |  News | 0 Comment | 29 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with obinu...Read more

Basilea announces collaboration with Roche

Drug Discovery |  News | 0 Comment | 25 Jan, 2019

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche to explore a combination of Basilea's derazantinib and Roche's PD-L1-...Read more

Wren Therapeutics completes £18M Series A Financing

Drug Discovery |  News | 0 Comment | 23 Jan, 2019

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases has announced that it has completed a Series A financing round. The ...Read more

AbbVie provides update on Phase 3 Study of IMBRUVICA

Drug Discovery |  News | 0 Comment | 22 Jan, 2019

AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-1137) of ibrutinib (IMBRUVICA®) in combination with chemotherapy age...Read more

Everest Medicines signs new deal targeting drug resistance

Drug Discovery |  News | 0 Comment | 14 Jan, 2019

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more

Janssen submits application to EMA seeking approval of STELARA

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation Application to the European Medicines Agency (EMA) seeking approval o...Read more

Denali Therapeutics announces Phase 1B Study of DNL747

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases has announced initiation of dosing in a Phase 1b ...Read more

Japan approves Amgen's osteoporosis drug

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorization for EVENITY (romosozumab) for the treatment of osteoporosis in pa...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for esaxerenone tablets, MINN...Read more

Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Drug Discovery |  News | 0 Comment | 09 Jan, 2019

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, has announced the initi...Read more